Related Experiment Video
Updated: Feb 2, 2026

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Current Cell-Based Therapies in the Chronic Liver Diseases
Taketo Nishina1, Kyoko Tomita Hoshikawa1,2, Yoshiyuki Ueno3,4
1Department of Gastroenterology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Chronic liver failure, a leading cause of death, lacks effective treatments beyond limited liver transplants. Muse cell therapy presents a promising innovative cellular approach for this condition.
Area of Science:
- Regenerative Medicine
- Hepatology
- Stem Cell Biology
Background:
- Liver diseases, particularly liver cirrhosis, are a major global health concern, leading to significant mortality.
- Current treatments for end-stage liver disease are limited, with liver transplantation being the only established option, but facing scarcity.
- Existing cellular therapies, including bone marrow-derived and peripheral blood-derived stem cells, have shown limited efficacy in clinical trials.
Purpose of the Study:
- To review the current development and status of cellular therapy for chronic liver failure.
- To highlight the limitations of existing stem cell therapies for liver disease.
- To emphasize Muse cell therapy as a potential innovative solution.
Main Methods:
- Review of existing literature on cellular therapies for liver disease.
- Analysis of clinical trial outcomes for stem cell-based treatments.
- Focus on the advancements and potential of Muse cells in regenerative medicine.
Main Results:
- Previous cellular therapies have not consistently demonstrated efficacy in treating chronic liver failure.
- Muse cells represent an advanced cellular fraction with potential therapeutic benefits.
- Further research and clinical trials are needed to establish the efficacy of Muse cell therapy.
Conclusions:
- Innovative cellular therapies are crucial for addressing the unmet needs in treating chronic liver failure.
- Muse cell administration is a promising remaining approach for developing effective treatments.
- The article discusses the progress and future prospects of Muse cell therapy for liver regeneration.
More Related Videos
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation